Trump's Pharma Pricing Deal Expands as Healthcare Stocks Keep Climbing
Trump expanded his drug pricing deal to 26 pharma firms as UBS says healthcare stocks still have room to climb.
Opent in een nieuw tabblad. Via Cryptopage meten we de klik voor statistieken.
Partner